Package 66993-457-30

Brand: dapagliflozin

Generic: dapagliflozin
NDC Package

Package Facts

Identity

Package NDC 66993-457-30
Digits Only 6699345730
Product NDC 66993-457
Product ID 66993-457_8d1c787c-dc29-4d26-bc99-77eeca055b8c
Description

30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (66993-457-30)

Marketing

Marketing Status
Marketed Since 2024-01-03
Brand dapagliflozin
Generic dapagliflozin
Sample Package No

Linked Drug Pages (1)

DAPAGLIFLOZIN ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "8d1c787c-dc29-4d26-bc99-77eeca055b8c", "openfda": {"unii": ["887K2391VH"], "rxcui": ["1488569", "1488574"], "spl_set_id": ["3aba33aa-f8c6-4b10-85c8-dfa14578d07c"], "manufacturer_name": ["Prasco Laboratories"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (66993-457-30)", "package_ndc": "66993-457-30", "marketing_start_date": "20240103"}], "brand_name": "DAPAGLIFLOZIN", "product_id": "66993-457_8d1c787c-dc29-4d26-bc99-77eeca055b8c", "dosage_form": "TABLET, FILM COATED", "pharm_class": ["Sodium-Glucose Cotransporter 2 Inhibitor [EPC]", "Sodium-Glucose Transporter 2 Inhibitors [MoA]"], "product_ndc": "66993-457", "generic_name": "DAPAGLIFLOZIN", "labeler_name": "Prasco Laboratories", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "DAPAGLIFLOZIN", "active_ingredients": [{"name": "DAPAGLIFLOZIN PROPANEDIOL", "strength": "10 mg/1"}], "application_number": "NDA202293", "marketing_category": "NDA AUTHORIZED GENERIC", "marketing_start_date": "20240103", "listing_expiration_date": "20261231"}